Norgen Biotek is a Canada-based company focusing on leading-edge biotechnology and the creation of products related to sample collection, preparation, and detection. Norgen also offers excellent research services for the scientific community.
Cancer Treatment Options and Management (CTOAM) has partnered with Norgen for many years. It is thanks to this partnership that we are able to offer our highly innovative and effective blood-based testing for early cancer detection and for identifying the best possible treatment options for our patients.
Norgen Biotek provides the base materials for some of the blood-based diagnostic innovations that CTOAM’s sister company, Liquid Biopsy Labs, produces. For example, our lead cancer expert, Alex Rolland, has been using Norgen’s plasma/serum workflow for Liquid Biopsy Labs’ newest liquid biopsy (ctDNA) test.
Our science team at Cancer Treatment Options and Management (CTOAM) and Liquid Biopsy Labs appreciates the quality and thoroughness of Norgen Biotek’s scientific products and the comprehensive research that supports all of their work.
We share similar goals in using biotechnological innovations to help solve major problems in the world – such as the treatment of cancer. CTOAM and Liquid Biopsy Labs appreciate our partnership with Norgen Biotek and look forward to producing more exciting advancements together in the coming years.
In this video interview led by Norgen’s Dr. M. Abdalla, CTOAM’s cancer expert, Alex Rolland, shares how liquid biopsy can be used to enhance Precision Cancer Medicine. Alex discusses the extensive work he’s been doing with Norgen’s plasma/serum workflow to create a liquid biopsy that can detect cancer in a patient far sooner than it could be identified with any other diagnostic tool.
If you’d like to find out how to access the very best treatments and diagnostics for your cancer care, as fast as possible, reach out today.
Have questions? Email us anytime.
Please note: CTOAM does not earn any commission from any person, company, or organization that we promote, work with, partner with, or recommend to our patients and clients. Any recommendations we make are completely non-biased and entirely evidence-based. This has been our policy from day one, and will remain as such.
CTOAM is a Canadian-based personalized cancer research and advocacy service that connects cancer patients and their oncologists with the newest advancements in personalized cancer care and precision oncology. We serve patients and doctors worldwide.
"I can’t tell you how much your support means to me. My call today with you was invaluable. You came into our lives at the perfect time. It’s rare to just be able to talk without a sales pitch. I could tell that my needs were more important." - Diane
Explore today’s precision cancer medicine research before making important treatment decisions. Get your questions answered now
Join over 20,000 patients, caregivers and advocates who rely on CTOAM for trusted updates on precision cancer medicine, molecular testing, biomarker discoveries, clinical trials, emerging diagnostics, and research-based educational resources designed to help you navigate today’s rapidly evolving cancer landscape.
Explore today’s precision cancer medicine research before making important treatment decisions.